EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 25 / Numéro 8-9 (Août-Septembre 2009) Med Sci (Paris), 25 8-9 (2009) 713-718 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 8-9, Août-Septembre 2009
Page(s) 713 - 718
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009258-9713
Publié en ligne 15 août 2009
  1. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4 : 525–33. [Google Scholar]
  2. McEwen BS. Steroid hormones and brain development: some guidelines for understanding actions of pseudohormones and other toxic agents. Environ Health Perspect 1987; 74 : 177–84. [Google Scholar]
  3. Ozawa H. Steroid hormones, their receptors and neuroendocrine system.J Nippon Med Sch 2005; 72 : 316–25. [Google Scholar]
  4. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005; 54 : 20–3. [Google Scholar]
  5. Nichols NR, Agolley D, Zieba M, Bye N. Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration. Brain Res Rev 2005; 48 : 287–301. [Google Scholar]
  6. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane database Syst Rev 2000; 2 : CD000065. [Google Scholar]
  7. Lee SK. Variations in practice and outcomes in the canadian NICU Network 1996-1997. Pediatrics 2000; 106 : 1070–9. [Google Scholar]
  8. Lemons JA. Very low birth weight outcomes of the National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001; 107 : E1. [Google Scholar]
  9. Desnoulez L, Empana J, Anceschi M, Breart G, Truffert P. Prise en charge de l’immaturité pulmonaire en néonatologie : enquête sur les pratiques européennes. Arch Pediatr 2005; 12 : 4–9. [Google Scholar]
  10. Halliday HL. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1 : CD001146. [Google Scholar]
  11. Yeh TF, Lin YJ, Hsieh WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 1997; 100 : E3. [Google Scholar]
  12. Lin YJ. The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two year follow-up study. Acta Paediatr 2005; 94 : 310–6. [Google Scholar]
  13. Shinwell ES. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83 : F177-F181. [Google Scholar]
  14. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344 : 95–101. [Google Scholar]
  15. Baud O, Foix-L’Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 341 : 1190–6. [Google Scholar]
  16. Spinillo A, Viazzo F, Colleoni R, et al. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004;191 : 217–24. [Google Scholar]
  17. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 350 : 1304–13. [Google Scholar]
  18. Murphy BP, Inder TE, Huppi PS, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001; 107 : 217–21. [Google Scholar]
  19. Baud O, Verney C, Evrard P, Gressens P. Injectable dexamethasone administration enhances cortical GABAergic neuronal differentiation in a novel model of postnatal steroid therapy in mice. Pediatr Res 2005;57 : 149–56. [Google Scholar]
  20. Baud O. Antenatal corticosteroid therapy: benefits and risks. Acta Paediatr Suppl 2004; 93 : 6–10. [Google Scholar]
  21. Baud O, Laudenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 2001; 50 : 706–11. [Google Scholar]
  22. American Academy of Pediatrics and Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109 : 330–8. [Google Scholar]
  23. Heine VM, Rowitch DH. Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11[beta]HSD2-dependent mechanism. J Clin Invest 2009; 119 : 267–77. [Google Scholar]
  24. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008; 22 : 2454–72. [Google Scholar]
  25. Ruiz i Altaba A. Hedgehog-Gli signaling in human disease. Georgetown, Texas, USA : Landes Bioscience, 2006 : 228 p. [Google Scholar]
  26. Holmes MC, Seckl JR. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol 2006; 248 : 9–14. [Google Scholar]
  27. Lewis PM, Dunn MP, McMahon JA, et al. Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 2001; 105 : 599–612. [Google Scholar]
  28. Dwyer JR, Sever N, Carlson M, et al. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 2007; 282 : 8959–68. [Google Scholar]
  29. Lee K, Jeong J, Tsai MJ, et al. Molecular mechanisms involved in progesterone receptor regulation of uterine function. J Steroid Biochem Mol Biol 2006; 102 : 41–50. [Google Scholar]
  30. Katayama S, Ashizawa K, Gohma H, et al. The expression of Hedgehog genes (Ihh, Dhh) and Hedgehog target genes (Ptc1, Gli1, Coup-TfII) is affected by estrogenic stimuli in the uterus of immature female rats. Toxicol Appl Pharmacol 2006; 217 : 375–83. [Google Scholar]
  31. Prins GS, Huang L, Birch L, Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci 2006; 1089 : 1–13. [Google Scholar]
  32. Pu Y, Huang L, Birch L, Prins GS. Androgen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathways. Endocrinology 2007;148 : 1697–706. [Google Scholar]
  33. Kim BJ, Takamoto N, Yan J, et al. Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum. Dev Biol 2009; 15 : 378–91. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.